Found: 53
Select item for more details and to access through your institution.
Challenges in the treatment of soft-tissue plasmacytoma: a retrospective analysis of 120 patients with extramedullary multiple myeloma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 10, p. 1, doi. 10.1007/s00432-024-05993-y
- By:
- Publication type:
- Article
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4611, doi. 10.1007/s00432-022-04356-9
- By:
- Publication type:
- Article
Correction: Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow‑up of 14.4 years.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 5, p. 1171, doi. 10.1007/s00432-021-03702-7
- By:
- Publication type:
- Article
Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 3, p. 749, doi. 10.1007/s00432-019-03101-z
- By:
- Publication type:
- Article
Modified DHAP regimen in the salvage treatment of refractory or relapsed lymphomas.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 12, p. 3067, doi. 10.1007/s00432-019-03027-6
- By:
- Publication type:
- Article
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 8, p. 1581, doi. 10.1007/s00432-018-2671-z
- By:
- Publication type:
- Article
Bendamustine in heavily pre-treated patients with relapsed or refractory multiple myeloma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 12, p. 2205, doi. 10.1007/s00432-015-2014-2
- By:
- Publication type:
- Article
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2006, v. 57, n. 2, p. 317, doi. 10.1093/jac/dki440
- By:
- Publication type:
- Article
COVID‐19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post‐Pandemic Concerns About the Impact of Rituximab.
- Published in:
- ACR Open Rheumatology, 2024, v. 6, n. 8, p. 519, doi. 10.1002/acr2.11681
- By:
- Publication type:
- Article
Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0750-5
- By:
- Publication type:
- Article
Primary analysis of JUMP, a phase 3b, expanded‐access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 888, doi. 10.1111/bjh.16462
- By:
- Publication type:
- Article
Doubling rituximab in high‐risk patients with aggressive B‐cell lymphoma ‐results of the DENSE‐R‐MegaCHOEP trial.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 5, p. 760, doi. 10.1111/bjh.15710
- By:
- Publication type:
- Article
Anti‐CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 5, p. 833, doi. 10.1111/bjh.15181
- By:
- Publication type:
- Article
TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 6, p. 914, doi. 10.1111/bjh.13912
- By:
- Publication type:
- Article
Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma.
- Published in:
- Infection, 2022, v. 50, n. 4, p. 925, doi. 10.1007/s15010-022-01765-3
- By:
- Publication type:
- Article
Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD.
- Published in:
- Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-023-07421-x
- By:
- Publication type:
- Article
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 10, p. 2741, doi. 10.1007/s00277-023-05394-0
- By:
- Publication type:
- Article
Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 12, p. 2837, doi. 10.1007/s00277-020-04021-6
- By:
- Publication type:
- Article
Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 7, p. 1167, doi. 10.1007/s00277-014-2041-0
- By:
- Publication type:
- Article
Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4086, doi. 10.3390/cancers13164086
- By:
- Publication type:
- Article
Bony proliferations in rheumatoid arthritis, psoriatic arthritis and osteoarthritis using high‐resolution peripheral quantitative computed tomography—A systematic literature review.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 2, p. 1, doi. 10.1111/1756-185X.15068
- By:
- Publication type:
- Article
Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.633215
- By:
- Publication type:
- Article
RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1286700
- By:
- Publication type:
- Article
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 7, p. 975, doi. 10.1093/neuonc/nox204
- By:
- Publication type:
- Article
Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refracty acute myeloid leukemia in a randomized phase II study.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refractory acute myeloid leukemia in a randomized phase II study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial Re LApsE.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 1, p. 42, doi. 10.1111/ejh.12888
- By:
- Publication type:
- Article
Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells.
- Published in:
- BMC Medical Genomics, 2015, v. 8, p. 1, doi. 10.1186/s12920-015-0161-6
- By:
- Publication type:
- Article
How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1466803
- By:
- Publication type:
- Article
P-177: Predictive factors for severe infections and early death during novel agent-based induction therapy in newly diagnosed, transplant-eligible myeloma: a multicohort analysis from phase III trials.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S133, doi. 10.1016/S2152-2650(21)02304-1
- By:
- Publication type:
- Article
Impact of cytogenetics at relapse on prognosis and benefit from salvage autologous stem cell transplantation in the GMMG phase III trial ReLApsE.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e286, doi. 10.1016/j.clml.2019.09.471
- By:
- Publication type:
- Article
Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies.
- Published in:
- Intensive Care Medicine, 2002, v. 28, n. 9, p. 1294, doi. 10.1007/s00134-002-1420-5
- By:
- Publication type:
- Article
Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone)
- Published in:
- Annals of Hematology, 2008, v. 87, n. 9, p. 717, doi. 10.1007/s00277-008-0500-1
- By:
- Publication type:
- Article
Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 5, p. 785, doi. 10.1007/s00280-007-0535-3
- By:
- Publication type:
- Article
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00805-x
- By:
- Publication type:
- Article
Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00790-1
- By:
- Publication type:
- Article
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00772-9
- By:
- Publication type:
- Article
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 10, p. 1, doi. 10.1038/s41408-021-00558-5
- By:
- Publication type:
- Article
Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma.
- Published in:
- Transfusion, 2006, v. 46, n. 8, p. 1417, doi. 10.1111/j.1537-2995.2006.00911.x
- By:
- Publication type:
- Article
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 7, p. 1126, doi. 10.1038/s41416-023-02362-3
- By:
- Publication type:
- Article
Unusual clinico-pathological features in primary Hodgkin's lymphomas of the central nervous system.
- Published in:
- 2013
- By:
- Publication type:
- Report
Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse.
- Published in:
- Cancer Management & Research, 2022, v. 14, p. 547, doi. 10.2147/CMAR.S339846
- By:
- Publication type:
- Article
Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 2, p. 237, doi. 10.1111/bjh.12253
- By:
- Publication type:
- Article
Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Successful combination of anti-cd33 antibody (gemtuzumab ozogamicin) and minimal conditioning before second allografting in recurrent acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2003, v. 120, n. 6, p. 1093, doi. 10.1046/j.1365-2141.2003.04208_4.x
- By:
- Publication type:
- Article